Edition:
India

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.33USD
20 Jul 2018
Change (% chg)

$-0.16 (-3.56%)
Prev Close
$4.49
Open
$4.47
Day's High
$4.47
Day's Low
$4.32
Volume
107,865
Avg. Vol
305,815
52-wk High
$8.07
52-wk Low
$3.30

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 21.75 -0.183
FY 2017 Dec '17 18.68 -1.192
Sep '17 15.00 -0.197
Jun '17 15.14 -0.768
Mar '17 11.82 -0.215
FY 2016 Dec '16 9.53 -0.319
Sep '16 6.34 -0.394
Jun '16 9.29 -0.422
Mar '16 6.82 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 29.22 32.41 25.02 30.90
Quarter Ending Dec-18 6 32.49 34.91 25.98 33.58
Year Ending Dec-18 7 107.05 117.74 94.50 129.02
Year Ending Dec-19 7 182.73 239.70 128.70 194.21
Earnings (per share)
Quarter Ending Sep-18 8 -0.13 -0.09 -0.16 -0.06
Quarter Ending Dec-18 8 -0.11 -0.06 -0.15 0.04
Year Ending Dec-18 7 -0.58 -0.46 -0.67 -0.23
Year Ending Dec-19 8 -0.08 0.37 -0.32 0.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 133.79 65.94 44.94
EPS (TTM) % -28.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Keryx Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.35%
# of Holders: 174
Total Shares Held: 77,563,810
3 Mo. Net Change: -403,894
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 8
# Reduced Positions: 6
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.